Variations in the TSPO neuroinflammation-associated protein's structure correlates with worse survival outcomes for male glioblastoma brain cancer patients than females.
A diet high in processed foods leads to neuroinflammation and memory decline in older rats, a new study reports. Supplementing a processed food diet with DHA, an omega 3 fatty acid, helped mitigate memory problems and reduce inflammation.
Testing for specific inflammatory proteins in cerebrospinal fluid can help doctors to diagnose the early onset of Alzheimer's disease and track the progression of the disease in patients.
Mainly associated with COVID infection in the elderly, researchers report a young, otherwise healthy woman was diagnosed with COVID-19 CNS vasculitis following infection.
Mouse and human studies reveal Interleukin-3 may modify immune responses in the brain that cause cell death and lead to Alzheimer's disease.
Post-mortem studies of COVID-19 patients revealed significant signs of neuroinflammation and impaired brain circuits which researchers believe were caused by the disease. Researchers said the changes noticed in the brains of COVID patients were similar to the changes that occur in both Alzheimer's and Parkinson's disease.
Neuroinflammation may be a key player in the pathological brain changes produced as a result of chronic opioid use. Microglia is likely responsible for the majority of the changes.
COVID-19 can spark a severe immune response in the central nervous system, affecting immune cells in the vascular system and brain.
Researchers link the inflammation associated with chronic sinus infections to alterations in brain activity in networks that govern cognition, external stimuli, and introspection. The findings shed light on why people suffering from sinus infections often report poor concentration and other short-term cognitive problems.
A new whole-genome sequencing study has revealed thirteen novel genes associated with Alzheimer's disease. Researchers also found a new link between Alzheimer's and synaptic function.
Hymecromone, a commonly prescribed spasmolytic medication, is able to suppress immune response in astrocytes in the central nervous system.
Immune cells in the meninges monitor fluid released from the brain. If the fluid contains signs of infection, disease, or damage, the immune cells initiate an immune response to tackle the problem.
